Roche obtained 510 approval from the US Food and Drug Administration, and its novel COBAS® eplex respiratory pathogen test combination3 was approved, enabling the laboratory to tailor respiratory testing plans according to local patient needs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.